SIRFLOX clinical trial Selective Internal Radiation Therapy SIR-Spheres treatment liver metastases liver tumour colorectal cancer

SIRFLOX.com

Selective Internal Radiation Therapy using SIR-Spheres

Skip to main menu and site information
Sirtex.com website
Current path: Home

Meet sponsor representative

If you require further information regarding SIR-Spheres Y-90 resin microspheres or the SIRFLOX study you may request a meeting with a sponsor representative via the contact form.

Sponsor clinical research representatives visited or will be visiting the following major conferences, which may be an opportunity to meet. Please click on this button to request a meeting.

EASL: European Association for the Study of the Liver
Vienna, Au  22 - 26 April 2015
www.easl.eu

ECIO: European Conference on Interventional Oncology
Nice, Fr  22 - 25 Apr 2015
www.ecio.org

ASCO Annual Meeting
Chicago, USA 29 May -2 June 2015
www.asco.org

GEST: Global Embolization Symposium and Technologies
Seville, Sp  24 - 27 June 2015
www.gest2015.eu

WCGIC: World Congress on Gastrointestinal Cancer
Barcelona, Sp 1-4 July 2015
www.worldgicancer.com

CIRSE: Cardiovascular and Interventional Radiological Societey of Europe
Lisboa, Prt 22 - 29 Sept 2015
www.cirse.org

ESMO-ECCO-ESSO: European Multidisciplinary Cancer Congress - European Society of Surgical Oncology
Vienna, Au  25 - 29 Sept 2015
www.europeancancercongress.org - www.essoweb.org

 

W005-EUA-0315

About the SIRFLOX study

The SIRFLOX study is an international research study designed to evaluate a new treatment option for patients with colorectal cancer that has undergone metastatic spread to the liver.

Back to top


SIRFLOX clinical trial Selective Internal Radiation Therapy SIR-Spheres treatment liver metastases liver tumour colorectal cancer